Putnam Global Health Care Y
(PHSYX)
-0.12
-0.21%
| Symbol | Value ($) |
|---|---|
| Morningstar Rating | |
| Previous Close | 56.17 |
| Category | Health |
| Net Assets | 27.51 Mil |
| Yield | 0.00% |
| Morningstar Risk | Average |
| Morningstar Return | Below Average |
- Last NAV update 5/24/2013 4:00 PM ET
| NA |
|---|
| The investment seeks capital appreciation. The fund invests mainly in common stocks (growth or value stocks or both) of large and midsize companies worldwide that the manager believes have favorable investment potential. Potential investments include companies that manufacture health care supplies or provide health care-related services, and companies in the research, development, production and marketing of pharmaceuticals and biotechnology products. It may also use derivatives, and may engage in short sales of securities. The fund is non-diversified. |
| 2009 | 2010 | 2011 | 2012 | 2013 | |
|---|---|---|---|---|---|
| Return | 25.49% | 2.32% | -1.19% | 22.31% | 21.35% |
| Value ($) | 12,549.00 | 12,840.14 | 12,687.34 | 15,517.89 | 18,830.96 |
- Year to date performance as of 5/23/2013 8:00 PM ET
| Symbol | Value ($) |
|---|---|
| Fund Family | Putnam |
| Fund Manager | Kelsey Chen |
| Tenure (Years) | 8 |
| Fund Status | Open |
| Minimum Initial Purchase | 0.00 |
| Minimum IRA Investment | NA |
| Front Load | 0.00 |
| Expense Ratio | 0.49% |
| Symbol | Value ($) |
|---|---|
| 1 Month | 2.29% |
| 3 Months | 13.29% |
| 1 Year | 41.25% |
| 3 Years* | 17.65% |
| 5 Years* | 10.53% |
- * Annualized returns
- Performance as of 5/23/2013 8:00 PM ET
| PHSYX | Health | |
|---|---|---|
| 5-Yr Return | 10.53% | 12.34% |
| Sharpe Ratio | 0.80 | 1.13 |
| Net Assets | 27.51 Mil | 504.68 Mil |
| Avg Market Cap | 35.04 Bil | 18.61 Bil |
| Avg P/E | 17.97 | 18.60 |
| Portfolio Turnover | 25 | 48 |
| Symbol | Value ($) |
|---|---|
| Stocks | 98.33% |
| Cash | 1.21% |
| Fixed Income | 0.00% |
| Other | 0.45% |
| NAME | % NET ASSETS |
|---|---|
| Johnson & Johnson | 7.25% |
| Pfizer Inc | 6.74% |
| Eli Lilly and Company | 5.09% |
| Sanofi | 4.70% |
| Celgene Corporation | 4.62% |
| Aetna Inc | 4.31% |
| Merck & Co Inc | 4.01% |
| GlaxoSmithKline PLC | 3.78% |
| AbbVie Inc | 3.49% |
| Covidien PLC | 2.83% |
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
